Vect-Horus
Develops targeting technology to transport therapeutic and imaging agents across the blood–brain barrier for pharma and biotech partners
Highlights
- New on EvolcAdded 2026-10-30
About Vect-Horus
Vect-Horus develops VECTrans®, a targeting technology for transporting therapeutic and imaging agents, including nucleic-acid therapies, to the brain.
The company works with pharmaceutical and biotechnology partners through research collaborations and licensing agreements. It also collaborates with academic research centers including AMU, CEA, CNRS and INSERM.
Founded in 2005, Vect-Horus is a spin-off of a CNRS and Aix-Marseille University research unit. It is based in Marseille, France, and has 38 employees, mostly in R&D.
Product: VECTrans®, a targeting technology for transporting therapeutic and imaging agents, including nucleic-acid therapies, to the brain.
Jobs at Vect-Horus
Leadership
- Michel KHRESTCHATISKY · Co-founder and scientific counselSource: company website
- Alexandre TOKAY · CEO and co-founderSource: company website
- Carole IMBERT · Chief Financial OfficerSource: company website
- Florence FERCHAT · Human Resources ManagerSource: company website
More biotech & pharma companies
Vivet Therapeutics
Clinical-stage gene therapy developer for rare inherited liver metabolic diseases, based in ParisNew on EvolcWhitelab Genomics
AI and computational biology tools for biotech and pharmaceutical teams developing genomic medicinesNew on EvolcXenothera
Develops glyco-humanized antibody treatments for patients with a range of therapeutic needsNew on EvolcZymoptiq
Enzyme activity testing products and analytical services for industrial and research customersNew on Evolc4P-Pharma
Clinical-stage biotech developing drug candidates for serious diseases with unmet medical needsNew on EvolcAb Science
Develops pharmaceutical compounds for clinical programs in neurology, inflammatory diseases, oncology and viral diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- nginx
